Background: Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported.
Case Presentation: In this study, we report a case of cystinuria with xanthine stones and hyperuricemia. The 23-year-old male patient was diagnosed with kidney and ureteral stones, solitary functioning kidney and hyperuricemia after admission to the hospital. The stones were removed by surgery and found to be composed of xanthine.
Conclusion: Genetic testing by next-generation sequencing technology showed that the patient carried the homozygous nonsense mutation c.1113 C> A (p.Tyr371*) in the SLC3A1 gene, which was judged to be a functionally pathogenic variant. Sanger sequencing revealed that the patient's parents carried this heterozygous mutation, which is a pathogenic variant that can cause cystinuria. The 24-h urine metabolism analysis showed that the cystine content was 644 mg (<320 mg/24 h), indicating that the patient had cystinuria, consistent with the genetic test results. This case shows that cystinuria and xanthine stones can occur simultaneously, and provides evidence of a possible connection between the two conditions. Furthermore, our findings demonstrate the potential value of genetic testing using next-generation sequencing to effectively assist in the clinical diagnosis and treatment of patients with urinary calculi.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391995 | PMC |
http://dx.doi.org/10.1186/s12894-023-01300-y | DOI Listing |
J Inflamm Res
January 2025
Department of Internal Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, People's Republic of China.
Purpose: Serum uric acid (SUA) is primarily produced through the hydrolysis of purines in the liver, with its excretion largely handled by the kidneys. Urate transporter 1 (URAT1) inhibitors are known to enhance uric acid elimination via the kidneys, but they also increase the risk of kidney stone formation. Currently, xanthine oxidase (XO) inhibitors are the predominant uric-lowering medications on the market.
View Article and Find Full Text PDFArch Ital Urol Androl
November 2024
C.d.C. Ambrosiana, Cesano Boscone, Milan.
Theobromine (or 3,7-dimethylxanthine) is a natural alkaloid present in cocoa plant and its derivatives, such as chocolate. About 20% of ingested theobromine is excreted unchanged in the urine. Theobromine also derived from caffeine that is metabolized into theobromine by 12%.
View Article and Find Full Text PDFArch Esp Urol
November 2024
Department of Urology, Affiliated Hospital of Qingdao University, 266000 Qingdao, Shandong, China.
Sci Rep
December 2024
Department of Urology, Qinghai University Affiliated Hospital, Xining, 810000, China.
Anal Methods
January 2025
Research Center of Jiangxi Province for Engineering Technology of Calculus Prevention and Control, Gannan Medical University, Ganzhou 341000, P. R. China.
Accurate determination of elemental concentrations in uric acid (UA) stones is crucial for understanding their formation process. However, the lack of matrix-matched calibration standards has limited the application of laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) in this field. This study addresses this limitation by preparing a synthetic UA precipitate (UA-1) doped with 17 elements using a recrystallization method.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!